bivalirudin Injection [Angiomax]
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Bivalirudin (Angiomax®, The Medicines Company, NJ, USA) is a direct-acting synthetic antithrombotic agent that has been approved…